Immune regulatory markers of lepidic-pattern adenocarcinomas presenting as ground glass opacities
David B. Nelson(The University of Texas MD Anderson Cancer Center), Mara B. Antonoff(The University of Texas MD Anderson Cancer Center)
Cited by 8
Related Papers
Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study
|The Lancet Digital Health|2023|108
Sleeve resection after neoadjuvant chemoimmunotherapy in the treatment of locally advanced non-small cell lung cancer
|Translational Lung Cancer Research|2022|19